Indications
- Breast Cancer (see Breast Cancer, [[Breast Cancer]])
Pharmacology
- Tyrosine Kinase Inhibitor
- Epidermal Growth Factor Receptor (EGFR)
- erbB-2 (HER2)
Administration
- XXX
Dose Adjustment
- Hepatic
- Renal
Adverse Effects
Other Adverse Effects
- xxx
References
- xxx